Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Health Psychol. 2013 Aug 19;33(10):1103–1112. doi: 10.1037/a0033756

Table 3.

Demographic and Medical Data for Survivors (n = 186)

Characteristic Frequency Percent
Survivor education and work (n = 1 missing)
    No school or work 33 17.70
    School 74 39.80
    Work with or without school 78 41.90
Survivor age in years
    14–19 82 44.1
    20–24 73 39.2
    25–29 19 10.2
    30–39 12 6.5
Treatment intensity
    1. Resection only 62 33.30
    2. Focal radiation ± non-intensive chemotherapy 55 29.60
    3. Moderate chemotherapy ± focal radiation, but no CSI 19 10.20
    4. Craniospinal radiation ± moderate/non-intensive chemotherapy or intensive chemotherapy and stem cell rescue 45 24.20
    5. Craniospinal radiation and intensive chemotherapy and stem cell rescue 5 2.70
Medical sequelae
    1. Minimal to no limitation in activity 31 16.70
    2. Mild restriction of daily activity 48 25.80
    3. Moderate restriction of daily activity 89 47.90
    4. Severe restriction of daily activity; life threatening 18 9.70
Tumor locations
    Posterior fossa/cerebellar 94 50.54
    Cortical/subcortical: all lobes 33 17.74
    Suprasellar/hypothalamic (included pituitary) 29 15.59
    Pineal 7 3.76
    Thalamic/basal ganglia 6 3.23
    Ventricle (supratentorial) 6 3.23
    Brain stem (tectal) 5 2.69
    Optic nerve/chiasm 4 2.15
    Brain NOS 2 1.08
Diagnoses
    Low grade glioma 94 50.54
    Primitive neuroectodermal tumors (PNET)/medulloblastoma 51 27.42
    Craniopharyngioma 14 7.53
    High grade glioma 7 3.76
    Ependymoma 5 2.69
    Germinoma & nongerminoma germ cell 5 2.69
    Choroid Plexus 4 2.15
    Others 6 3.23